Index of reports
> Cases with Alanine Aminotransferase Increased (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Suprane (Desflurane) where reactions include alanine aminotransferase increased. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Suprane side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-20
Patient: 28 year old female
Reactions: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Abdominal Pain, Hepatic Function Abnormal, Alanine Aminotransferase Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone 4MG TAB
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
(Cyclizine)
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
(Pethidinhje)
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Start date: 2011-10-10
End date: 2011-10-10
(Remifentanil Hydrochloride)
Dosage: ntravenous (not otherwise specified)
Indication: General Anaesthesia
Ondansetron
Dosage: intravenous
Indication: General Anaesthesia
Fentanyl-100
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Suprane
Dosage: 1 total dose respiratory (inhalation)
Indication: General Anaesthesia
Start date: 2011-10-11
Suprane
Dosage: 1 total dose respiratory (inhalation)
Indication: Choledocholithotomy
Start date: 2011-10-11
Atracurium Besylate
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Scopolamine
Dosage: intravenous (not otherwise specified
Indication: General Anaesthesia
Start date: 2011-10-10
End date: 2011-10-10
Other drugs received by patient: (Antidepressants)
Possible Suprane side effects in 28 year old female
Reported by a consumer/non-health professional from United Kingdom on 2012-02-28
Patient: 28 year old female
Reactions: Refusal of Treatment by Patient, Abdominal Pain, Blood Bilirubin Increased, Post Procedural Complication, Alanine Aminotransferase Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclizine (NO Pref. Name)
Dosage: ; iv
Indication: General Anaesthesia
Meperidine Hydrochloride
Dosage: ; iv
Indication: General Anaesthesia
Start date: 2011-10-10
End date: 2011-10-10
Dexamethasone
Dosage: ; iv
Indication: General Anaesthesia
Fentanyl
Dosage: ;iv
Indication: General Anaesthesia
Scopolamine
Dosage: ; iv
Indication: General Anaesthesia
Start date: 2011-10-10
End date: 2011-10-10
Atracurium Besylate
Dosage: ; iv
Indication: General Anaesthesia
Suprane
Indication: Cholelithiasis
Start date: 2011-10-11
Ondansetron
Dosage: ; iv
Indication: General Anaesthesia
Remifentanil (NO Pref. Name)
Dosage: iv
Indication: General Anaesthesia
Possible Suprane side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-24
Patient: female, weighing 95.0 kg (209.0 pounds)
Reactions: Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Bile Duct Stone, Alanine Aminotransferase Increased, Liver Function Test Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethason (Dexamethason / 00016001)
Dosage: ;iv
Indication: Product Used FOR Unknown Indication
Cyclizine (Cyclizine)
Dosage: ;iv
Indication: Product Used FOR Unknown Indication
Remifentanil (Remifentanil)
Dosage: ;iv
Indication: Product Used FOR Unknown Indication
Ondansetron
Dosage: ;iv
Indication: Product Used FOR Unknown Indication
Meperidine Hydrochloride
Dosage: ;iv
Indication: General Anaesthesia
Start date: 2011-10-10
End date: 2011-10-10
Atracurium Besylate
Indication: Product Used FOR Unknown Indication
Suprane
Dosage: ;once; resp
Indication: General Anaesthesia
Start date: 2011-10-01
Suprane
Dosage: ;once; resp
Indication: Choledocholithotomy
Start date: 2011-10-01
Fentanyl
Dosage: ;iv
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Hyoscine HBR HYT
Possible Suprane side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-24
Patient: 28 year old female, weighing 95.0 kg (209.0 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Abdominal Pain, Alanine Aminotransferase Increased, Liver Function Test Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Scopolamine
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Ondansetron
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Dexamethasone
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Suprane
Dosage: 1 total dose, respiratory
Indication: Choledocholithotomy
Start date: 2011-10-11
Suprane
Dosage: 1 total dose, respiratory
Indication: General Anaesthesia
Start date: 2011-10-11
Fentanyl
Dosage: intravenous (not otherwise specified)
Indication: Anaesthesia
Cyclizine
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Atracurium Besylate
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Remifentanil Hydrochloride
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Meperidine HCL
Dosage: intravenous (not otherwise specified)
Indication: General Anaesthesia
Other drugs received by patient: Antidepressants
|